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Abstract 
Mycobacterium tuberculosis (MTB) is a pathogenic bacteria species in the genus Mycobacterium and the 
causative agent of most cases of tuberculosis. It is spread through the air when people who have an active MTB 
infection cough, sneeze, or otherwise transmit their saliva through the air. Most infections in humans result in an 
asymptomatic, latent infection, and about one in ten latent infections eventually progresses to active disease, 
which, if left untreated, kills more than 50% of its victims.  Mycobacterium tuberculosis is a member of the 
genus ‘tuberculosis’ in which contains various other mycobacterium species also. These species within a gene 
must have some similarity in them. In spite of this similarity only mycobacterium tuberculosis cause the 
tuberculosis disease, the remaining does not. This signifies that mycobacterium tuberculosis must be having 
some specific genes or proteins which are uniquely present only in it and not in the other species. This fact is 
used in this research and blast program is executed recursively for the comparison between these mycobacterium 
species. 
Keywords: BLAST, Mycobacterium Tuberculosis, Nontuberculous mycobacterium group, EEA1, KEGG 
 
1.  Introduction 
Tuberculosis, MTB or TB is a common and in some cases infectious disease caused by various strains of 
mycobacterium, usually Mycobacterium tuberculosis in humans. Tuberculosis usually attacks the lungs but can 
also affect other parts of the body. It is spread through the air when people who have an active MTB infection 
cough, sneeze, or otherwise transmit their saliva through the air. Most infections in humans result in an 
asymptomatic, latent infection, and about one in ten latent infections eventually progresses to active disease, 
which, if left untreated, kills more than 50% of its victims. 
    The classic symptoms are a chronic cough with blood-tinged sputum, fever, night sweats, and weight loss (the 
last giving rise to the formerly prevalent colloquial term "consumption"). Infection of other organs causes a wide 
range of symptoms. Diagnosis relies on radiology (commonly chest X-rays), a tuberculin skin test, blood tests, as 
well as microscopic examination and microbiological culture of bodily fluids. Treatment is difficult and requires 
long courses of multiple antibiotics. Contacts are also screened and treated if necessary. Antibiotic resistance is a 
growing problem in (extensively) multi-drug-resistant tuberculosis. Prevention relies on screening programs and 
vaccination, usually with Bacillus Calmette-Guérin vaccine. 
    One third of the world's population is thought to be infected with M. tuberculosis, and new infections occur 
at a rate of about one per second. The proportion of people who become sick with tuberculosis each year is stable 
or falling worldwide but, because of population growth, the absolute number of new cases is still increasing. In 
2007 there were an estimated 13.7 million chronic active cases, 9.3 million new cases, and 1.8 million deaths, 
mostly in developing countries. In addition, more people in the developed world contract tuberculosis because 
their immune systems are more likely to be compromised due to higher exposure to immunosuppressive drugs, 
substance abuse, or AIDS. The distribution of tuberculosis is not uniform across the globe; about 80% of the 
population in many Asian and African countries test positive in tuberculin tests, while only 5–10% of the US 
population test positive.
  
    The cause of TB, Mycobacterium tuberculosis (MTB), is a small aerobic non-motile bacillus. High lipid 
content of this pathogen accounts for many of its unique clinical characteristics. It divides every 16 to 20 hours, 
an extremely slow rate compared with other bacteria, which usually divide in less than an hour. (For example, 
one of the fastest-growing bacteria is a strain of     E. coli that can divide roughly every 20 minutes.) Since 
MTB has a cell wall but lacks a phospholipid outer membrane, it is classified as a Gram-positive bacterium. 
However, if a Gram stain is performed, MTB either stains very weakly Gram-positive or does not retain dye as a 
result of the high lipid & mycolic acid content of its cell wall. MTB can withstand weak disinfectants and 
survive in a dry state for weeks. In nature, the bacterium can grow only within the cells of a host organism, but 
M. tuberculosis can be cultured in vitro.  
      The M. tuberculosis complex includes four other TB-causing mycobacterium: M. bovis, M. africanum, M. 
canetti and M. microti. M. africanum is not widespread, but in parts of Africa it is a significant cause of 
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tuberculosis. M. bovis was once a common cause of tuberculosis, but the introduction of pasteurized milk has 
largely eliminated this as a public health problem in developed countries. M. canetti is rare and seems to be limited 
to Africa, although a few cases have been seen in African emigrants. M. microti is mostly seen in immunodeficient 
people, although it is possible that the prevalence of this pathogen has been underestimated.  
Other known pathogenic mycobacterium includes Mycobacterium leprae, Mycobacterium marinum, 
Mycobacterium avium and M. kansasii. The last two are part of the nontuberculous mycobacterium (NTM) group. 
Nontuberculous mycobacterium cause neither TB nor leprosy, but they do cause pulmonary diseases resembling 
TB.
  
      Mycobacterium tuberculosis (MTB) is a pathogenic bacteria species in the genus Mycobacterium and the 
causative agent of most cases of tuberculosis. First discovered in 1882 by Robert Koch, M. tuberculosis has an 
unusual, waxy coating on the cell surface (primarily mycolic acid), which makes the cells impervious to Gram 
staining so acid-fast detection techniques are used instead. The physiology of M. tuberculosis is highly aerobic and 
requires high levels of oxygen. Primarily a pathogen of the mammalian respiratory system, MTB infects the lungs. 
The most frequently used diagnostic methods for TB are the tuberculin skin test, acid-fast stain, and chest 
radiographs. The M. tuberculosis genome was sequenced in 1998.  
      M. tuberculosis requires oxygen to grow. It does not retain any bacteriological stain due to high lipid content 
in its wall, and thus is neither Gram positive nor Gram negative; hence Ziehl-Neelsen staining, or acid-fast 
staining, is used. While mycobacterium do not seem to fit the Gram-positive category from an empirical standpoint 
(i.e., they do not retain the crystal violet stain), they are classified as acid-fast Gram-positive bacteria due to their 
lack of an outer cell membrane. M. tuberculosis divides every 15–20 hours, which is extremely slow compared to 
other bacteria, which tend to have division times measured in minutes (Escherichia coli can divide roughly every 
20 minutes). It is a small bacillus that can withstand weak disinfectants and can survive in a dry state for weeks. Its 
unusual cell wall, rich in lipids (e.g., mycolic acid), is likely responsible for this resistance and is a key virulence 
factor. When in the lungs, M. tuberculosis is taken up by alveolar macrophages, but they are unable to digest the 
bacterium. Its cell wall prevents the fusion of the phagosome with a lysosome. Specifically, M. tuberculosis blocks 
the bridging molecule, early endosomal autoantigen 1 (EEA1); however, this blockade does not prevent fusion of 
vesicles filled with nutrients. Consequently, the bacteria multiply unchecked within the macrophage. The bacteria 
also carried the UreC gene, which prevents acidification of the phagosome. The bacteria also evade 
macrophage-killing by neutralizing reactive nitrogen intermediates. The ability to construct M. tuberculosis 
mutants and test individual gene products for specific functions has significantly advanced our understanding of 
the pathogenesis and virulence factors of M. tuberculosis. Many secreted and exported proteins are known to be 
important in pathogenesis. 
      M. tuberculosis comes from the genus Mycobacterium, which is composed of approximately 100 recognized 
and proposed species. The most familiar of the species are Mycobacterium tuberculosis and Mycobacterium leprae 
(leprosy). M. tuberculosis appears to be genetically diverse, which results in significant phenotypic differences 
between clinical isolates. M. tuberculosis exhibits a biogeographic population structure and different strain 
lineages are associated with different geographic regions. Phenotypic studies suggest this strain variation never has 
implications for the development of new diagnostics and vaccines. Microevolutionary variation affects the relative 
fitness and transmission dynamics of antibiotic-resistant strains. Mycobacterium outbreaks are often caused by 
hypervirulent strains of M. tuberculosis. In laboratory experiments, these clinical isolates elicit unusual 
immunopathology, and may be either hyperinflammatory or hypoinflammatory. Studies have shown the majority 
of hypervirulent mutants have deletions in their cell wall modifying enzymes or regulators that respond to 
environmental stimuli. Studies of these mutants have indicated the mechanisms that enable M. tuberculosis to 
mask its full pathogenic potential, inducing a granuloma that provides a protective niche and enables the bacilli to 
sustain a long-term, persistent infection.  
The genome of the H37Rv strain was published in 1998. Its size is 4 million base pairs, with 3959 genes; 40% of 
these genes have had their function characterized, with possible function postulated for another 44%. Within the 
genome are also 6 pseudogenes.The genome contains 250 genes involved in fatty acid metabolism, with 39 of 
these involved in the polyketide metabolism generating the waxy coat. Such large numbers of conserved genes 
show the evolutionary importance of the waxy coat to pathogen survival. About 10% of the coding capacity is 
taken up by two clustered gene families that encode acidic, glycine-rich proteins. These proteins have a conserved 
N-terminal motif, deletion of which impairs growth in macrophages and granulomas. Nine noncoding sRNAs 
have been characterized in M. tuberculosis, with a further 56 predicted  only an estimated 10% of people infected 
with M. tuberculosis ever develop the disease, and many of those have the disease only for the first few years 
following infection, even though the bacillus may lie dormant in the body for decades.  
       The symptoms that patients infected with M. tuberculosis may experience are usually absent until the 
disease has become more complicated. It may take many months from the time the infection initially gets into the 
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lungs until symptoms develop. Cough is however the first symptom of the infection with M. tuberculosis.  The 
initial symptoms, including loss of appetite, fever, productive cough and loss of energy or loss of weight or night 
sweats, are not specific and might be easily attributed to another condition. Primary pulmonary tuberculosis is the 
first stage of the condition, and it may cause fever, dry cough and some abnormalities that may be noticed on a 
chest X-ray. In most cases, though, primary infections tend to cause no symptoms that people do not overcome. 
This condition resolves itself, although it returns in more than half of the cases. 
       Tuberculosis causing lung disease may result in tuberculous pleuritis, a condition that may cause symptoms 
such as chest pain, nonproductive cough and fever. Moreover, infection with M. tuberculosis can spread to other 
parts of the body, especially in patients with a weakened immune system. This condition is referred to as miliary 
tuberculosis, and people contacting it may experience fever, weight loss, weakness and a poor appetite. In more 
rare cases, miliary tuberculosis can cause coughing and difficulty breathing. 
Only an estimated 10% of people infected with M. tuberculosis ever develop the disease, and many of those have 
the disease only for the first few years following infection, even though the bacillus may lie dormant in the body 
for decades. The symptoms that patients infected with M. tuberculosis may experience are usually absent until the 
disease has become more complicated. It may take many months from the time the infection initially gets into the 
lungs until symptoms develop. Cough is however the first symptom of the infection with M. tuberculosis.  The 
initial symptoms, including loss of appetite, fever, productive cough and loss of energy or loss of weight or night 
sweats, are not specific and might be easily attributed to another condition. Primary pulmonary tuberculosis is the 
first stage of the condition, and it may cause fever, dry cough and some abnormalities that may be noticed on a 
chest X-ray. In most cases, though, primary infections tend to cause no symptoms that people do not overcome. 
This condition resolves itself, although it returns in more than half of the cases. Tuberculosis causing lung disease 
may result in tuberculous pleuritis, a condition that may cause symptoms such as chest pain, nonproductive cough 
and fever. Moreover, infection with M. tuberculosis can spread to other parts of the body, especially in patients 
with a weakened immune system. This condition is referred to as miliary tuberculosis, and people contacting it 
may experience fever, weight loss, weakness and a poor appetite. In more rare cases, miliary tuberculosis can 
cause coughing and difficulty breathing. 
 
2. Method 
The present study was conducted at the department of Bioinformatics, Maulana Azad National Institute of 
Technology, Madhya Pradesh, India. Institutional ethical board approved the study and the informed consent was 
obtained from all the subjects before the commencement. 
 
 2.1. Database used for comparative study of 11 different M. tuberculosis species (table.1) 
KEGG (Kyoto Encyclopedia of Genes and Genomes) is a collection of online databases dealing with 
genomes, enzymatic pathways, and biological chemicals. The PATHWAY database records networks of 
molecular interactions in the cells, and variants of them specific to particular organisms. 
      KEGG connects known information on molecular interaction networks, such as pathways and complexes 
(this is the Pathway Database), information about genes and proteins generated by genome projects (including the 
gene database) and information about biochemical compounds and reactions (including compound and reaction 
databases). These databases are different networks, known as the protein network, and the chemical universe 
respectively. There are efforts in progress to add to the knowledge of KEGG, including information regarding 
ortholog clusters in the KO (KEGG Orthology) database.  
 
2.2 Tools & Software’s used for comparative study of 11 different M. tuberculosis species 
 
2.2.1 BLAST Tool 
BLAST, or Basic Local Alignment Search Tool is an algorithm for comparing primary biological sequence 
information, such as the amino-acid sequences of different proteins or the nucleotides of DNA sequences. A 
BLAST search enables a researcher to compare a query sequence with a library or database of sequences, and 
identify library sequences that resemble the query sequence above a certain threshold. Different types of 
BLASTs are available according to the query sequences. For example, following the discovery of a previously 
unknown gene in the mouse, a scientist will typically perform a BLAST search of the human genome to see if 
humans carry a similar gene; BLAST will identify sequences in the human genome that resemble the mouse 
gene based on similarity of sequence. The BLAST program was designed by Eugene Myers, Stephen Altschul, 
Warren Gish, David J. Lipman, and Webb Miller at the NIH and was published in the Journal of Molecular 
Biology in 1990. 
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2.2.2 BlastClust Tool 
     BLASTClust is a program within the standalone BLAST package used to cluster either protein or 
nucleotide sequences. The program begins with pairwise matches and places a sequence in a cluster if the 
sequence matches at least one sequence already in the cluster. In the case of proteins, the blastp algorithm is used 
to compute the pairwise matches; in the case of nucleotide sequences, the Megablast algorithm is used. In the 
simplest case, BLASTClust takes as input a file containing catenated FASTA-format sequences, each with a 
unique identifier at the start of the definition line. BLASTClust formats the input sequence to produce a 
temporary BLAST database, performs the clustering, and removes the database at completion. Hence, there is no 
need to run formatdb in advance to use BLASTClust. The output of BLASTClust consists of a file, one cluster to 
a line, of sequence identifiers separated by spaces. The clusters are sorted from the largest cluster to the smallest. 
     BLASTClust accepts a number of parameters that can be used to control the stringency of clustering 
including thresholds for score density, percent identity, and alignment length. The BLASTClust program has a 
number of applications, the simplest of which is to create a non-redundant set of sequences from a source 
database. As an example, one might have a library of a few thousand short nucleotide sequence reads and wish to 
replace these with a non-redundant set. To produce the non-redundant set, one might use:  
Blastclust -i infile -o outfile -p F -L .9 -b T -S 95 
The sequences in "infile" will be clustered and the results will be written to "outfile". The input sequences are 
identified as nucleotide (-p F); "-p T", or protein, is the default. To register a pairwise match two sequences will 
need to be 95% identical (-S 95) over an area covering 90% of the length (-L .9) of each sequence (-b T). Using 
"-b F" instead of "-b T" would enforce the alignment length threshold on only one member of a sequence pair. 
The parameter "S", used here to specify the percent identity, can also be used to specify, instead, a "score 
density." The latter is equivalent to the BLAST score divided by the alignment length. If "S" is given as a 
number between 0 and 3, it is interpreted as a score density threshold; otherwise it is interpreted as a 
percent_identity_threshold. 
To create a stringent non-redundant protein sequence set, use the following command line:  
Blastclust -i infile -o outfile -p T -L 1 -b T -S 100 
In this case, only sequences which are identical will be clustered together. The “blastclust.txt” file in the 
standalone BLAST package details the full range of BLASTClust parameters. 
 
2.2.3 Downloading Genomes & Proteomes 
Genome and proteomes of the 11 organisms is downloaded from the data repository KEGG (Kyoto 
Encyclopedia of Genes and Genomes)                                       
Mtu (Mycobacterium tuberculosis H37Rv)  
Mle (Mycobacterium Leprae)  
Mbo (Mycobacterium Bovis)  
Msm (Mycobacterium Smegmatis)  
Mmi (Mycobacterium Marinum)   
Mpa (Mycobacterium avian Para tuberculosis) 
Mgi (Mycobacterium Flavescens (gilvum))   
Mva (Mycobacterium Vanbaalenii)  
Mkm (Mycobacterium sp KMS)  
Mjl (Mycobacterium sp JLS)  
Mmc (Mycobacterium sp MCS)  
 
2.2.4 Installation of BLAST 
     The blast+ archive downloaded above contains a built-in installer. Accepting the license agreement after 
double-clicking, the installer will prompt for an installation directory. The default installation directory in this 
test case is "C:\blast-2.2.23+". Clicking the "Install" button, the installer will create a "doc" subdirectory 
containing a comprehensive user manual in pdf format, an "uninstaller" for future removal of the installation, 
and a "bin" subdirectory where the following BLAST programs and accessory utilities are kept.  
blastdbcheck.exe      blastdbcmd.exe            blastdb_aliastool.exe 
blastn.exe            blastp.exe                blastx.exe 
blast_formatter.exe   convert2blastmask.exe     dustmasker.exe 
legacy_blast.pl       makeblastdb.exe           makembindex.exe 
psiblast.exe          rpsblast.exe              rpstblastn.exe 
segmasker.exe         tblastn.exe tblastx.exe   update_blastdb.pl 
windowmasker.exe 
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There is another subdirectory which is created during the installation of BLAST “data”. This directory contains 
some files like 
    asn2ff.prt  blosum45 blosum62 blosum80 bstdt.val ecnum_ambiguous ecnum_specific UniVec.nhr
 sgmlbb.ent 
 
These are supporting files required by the BLAST program to run successfully. So these files are copied and 
shifted into the subdirectory “bin”.  
 
2.2.5 Output file of BlastClust 
The output file generated by BLASTclust program on its execution contains cluters of sequences.  
This output file ‘sequences_1.0_100_complete.ssv’ is filtered using MS Access Database management tool. 
After using MS Access the following type of data is obtained: 
Unique genes in every strain seperately 
Total common clusters 
 
2.2.6 Executing BLAST with composite Proteome file 
For composite protein file (all_proteomes.txt) exactly same procedure is applied as that of composite genome file 
except for the blastclust command which is 
blastclust -a 1 -i all_genomes.txt –p T  -o sequences_1.0_100_complete.ssv –S 100 -L 1.0 
The parellel execution of BLASTclust for genome data is done to validate the final results we get from proteome 
analysis.   
 
3. Results 
 
3.1 Proteome Results 
Starting from the set of values (100% identity and 100% sequence coverage) the set of values was lowered down 
upto (1% identity and 1% sequence coverage). (Table 2) 
According to comparative analysis we are concerned with lowering down the number of unique proteins in m. 
tuberculosis so only relevant results are shown in form of tables while the whole results are presented (Fig.1) 
graphically. 
The sizes of respective proteomes 11 different species of Mycobacterium are: 
Mtu (Mycobacterium tuberculosis H37Rv) =3988 
Mle (Mycobacterium Leprae) =1605 
Mbo (Mycobacterium Bovis) =3918 
Msm (Mycobacterium Smegmatis) =6716 
Mmi (Mycobacterium Marinum) =5452 
Mpa (Mycobacterium avian Para tuberculosis)=4350 
Mgi (Mycobacterium Flavescens (gilvum)) =5579 
Mva (Mycobacterium Vanbaalenii) =5979 
Mkm (Mycobacterium sp KMS) =5975 
Mjl (Mycobacterium sp JLS) =5739 
Mmc (Mycobacterium sp MCS) =5615 
Total = 54916 
On further decrease in sequence coverage, no decrease in the number of unique proteins in mycobacterium 
tuberculosis was noticed. 
 
3.2 Unique proteins in Mycobacterium tuberculosis 
Mtu: Rv1515c  
Mtu: Rv1509  
Mtu: Rv1507A  
Mtu: Rv2645  
Mtu: Rv2658c  
Mtu: Rv2653c  
Mtu: Rv2654c  
Mtu: Rv3599c 
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3.3 Genome results 
Starting from the set of values (100% identity and 100% sequence coverage) the set of values was lowered down 
upto (1% identity and 1% sequence coverage).  According to comparative analysis we are concerned with 
lowering down the number of unique genes in m. tuberculosis so only relevant results are shown in form of table 
3. 
According to comparative analysis 23 unique genes obtained are those genes which have no similarity with any 
other genes in the remaining 10 mycobacterium strains i.e. they are specific to mtu only.                                
 The sizes of respective genomes are:                                                                                            
Mtu (Mycobacterium tuberculosis H37Rv) =4047 
Mle (Mycobacterium Leprae) =2770 
Mbo (Mycobacterium Bovis) =4001 
Msm (Mycobacterium Smegmatis) =6938 
Mmi (Mycobacterium Marinum) =5570 
Mpa (Mycobacterium avian Para tuberculosis) =4399 
Mgi (Mycobacterium Flavescens (gilvum)) =5669 
Mva (Mycobacterium Vanbaalenii) =6139 
Mkm (Mycobacterium sp KMS) =6079 
Mjl (Mycobacterium sp JLS) =5845 
Mmc (Mycobacterium sp MCS) =5698 
Total = 54916 
 
4.     Discussion 
11 Mycobacterium strains were taken for the analysis 
Mtu (Mycobacterium tuberculosis H37Rv)  
Mle (Mycobacterium Leprae)  
Mbo (Mycobacterium Bovis)  
Msm (Mycobacterium Smegmatis)  
Mmi (Mycobacterium Marinum)  
Mpa (Mycobacterium avian Para tuberculosis) 
Mgi (Mycobacterium Flavescens (gilvum))  
Mva (Mycobacterium Vanbaalenii)  
Mkm (Mycobacterium sp KMS)  
Mjl (Mycobacterium sp JLS)  
Mmc (Mycobacterium sp MCS)  
 
• On executing blastclust on the whole proteome data, finally 8 unique proteins in the mycobacterium 
tuberculosis were present i.e. the proteins that were specific in the mtu strain only. 
• On executing blastclust on the whole genome data, finally 23 unique genes in the mycobacterium 
tuberculosis were presents i.e. the genes that were specific in the mtu strain only. 
Behalf on above studty we can easily idntify unique strains of 11 different Mycobacterium species which only 
found Mycobacterium  tuberculosis species. 
 
5.     Conclusion 
The 8 unique proteins obtained in the comparative proteome analysis and 23 unique genes are obtained in 
comparative genome analysis. These 8 unique proteins were also present in the list of proteins which are 
obtained from expression of the 23 unique genes. This validation check gives an important support to the 
analysis that the work done is valid and has given accurate results. Out of these 8 unique proteins 5 are 
hypothetical proteins and 3 proteins are prophage proteins. So one or more unique proteins obtained must be 
having role in the specific behavior of mtu strain which is responsible for causing the tuberculosis disease. This 
gives a strong support to the DRUG DEVELOPMENT and can be very beneficial in the drug discovery area 
because these proteins can directly or indirectly act as sensitive drug targets for a drug for tuberculosis. 
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Tables 
S.No. ORGANISM Short form Number of genes 
present 
Number of 
protein present 
1. M.tuberculosis Mtu 4047 3988 
2. M.bovis Mbo 4001 3918 
3. M.laprae Mle 2770 1605 
4. M.smegmatis Msm 6938 6716 
5. M.marinum Mmi 5570 5452 
6. M.avium_paratuberculosis Mpa 4399 4305 
7. M.gilvum Mgi 5669 5579 
8. M.vanbaalenii Mva 6136 5979 
9. Mycobacterium_JLS Mjl 5845 5739 
10. Mycobacterium_MCS Mmc 5698 5615 
11. Mycobacterium_KMS Mkm 6079 5975 
 
Table 1: Comparative study of Genome & Proteome genes of 11 different species of Mycobacterium 
 
Results for 20% sequence coverage 
Mycobacterium Unique protein Unique clusters 
Mtu 33(0.827%) 33 
Mbo 51(1.301%)  50 
Mle 141(8.785%) 141 
Mmi 477(8.749%) 463 
Mpa 244(5.609%) 241 
Msm 810(12.061%) 722 
Mgi 276(4.947%) 270 
Mva 332(5.552%) 320 
Mkm 85(1.4225%) 83 
Mjl 141(2.456%) 133 
Mmc 18(0.321%) 18 
Common --- 898 
 
Advances in Life Science and Technology                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol 5, 2012 
 
66 
 
 
Results for 10% sequence coverage 
 
 
Table 2: The marked section represents the unique proteins in the strain mycobacterium tuberculosis. These are 
the proteins which are not present in any of the remaining 10 strains i.e. they are specific to m. tuberculosis only 
(Acc. - to Proteome results)  
Results for 20% sequence coverage 
Mycobacterium Unique protein Unique clusters 
Mtu 40(%) 35 
Mbo 52(%) 52 
Mle 143(%) 141 
Mmi 479(%) 467 
Mpa 247(%) 245 
Msm 821(%) 730 
Mgi 276(%) 271 
Mva 335(%) 325 
Mkm 91(%) 86 
Mjl 145(%) 134 
Mmc 29(%) 19 
Common --- 919 
 
Table for 10% sequence coverage 
Mycobacterium Unique protein Unique clusters 
Mtu 23(%) 15 
Mbo 9( %) 11 
Mle 102(%) 99 
Mmi 412(%) 398 
Mpa 161(%) 165 
Msm 695(%) 654 
Mgi 207(%) 203 
Mva 289(%) 272 
Mkm 77(%) 74 
Mjl 111(%) 107 
Mmc 15(%) 13 
Common --- 741 
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Table 3: These 23 unique genes obtained are those genes which have no similarity with any other genes in the 
remaining 10 mycobacterium strains i.e. they are specific to mtu only. (Acc. to Genome results)                              
 
 
 
 
Figure 1: Graph shows the number of unique proteins in each mycobacterium strain against the sequence 
coverage parameter (% L value) 
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